Insmed (INSM) PT Raised to $40 at BofA Securities

February 23, 2024 6:30 AM

BofA Securities analyst Jason Zemansky raised the price target on Insmed (NASDAQ: INSM) to $40.00 (from $37.00) while maintaining a Buy rating.

No results found